Metsera, INC Form 4 insider transactions

Director Kristina Burow reports multiple transactions involving Metsera Inc. common stock and convertible preferred stock, including acquisitions and conversions.

Director Paul L. Berns reported acquiring and converting a substantial number of Metsera Inc. shares, both directly and indirectly, following the company's IPO.

ARCH Venture Partners and related entities have reported the acquisition of millions of shares of Metsera, Inc. common stock and the conversion of preferred stock following the company's IPO.

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. reported the conversion of Series B Preferred Stock to Common Stock in Metsera, Inc. following the company's IPO.